Toll-like receptors in sepsis: A tale still being told

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 10, Issue 3, 2010, Pages 285-291

  Souza, Heraldo Possolo ^a   Lima Salgado, Thais ^a   da Cruz Neto, Luis Monteiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Pattern recognition receptors; Sepsis; Toll like receptors

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FIBRINOGEN; FLAGELLIN; GLYCOSYLPHOSPHOPHATIDYL INOSITOL MUCIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEMAGGLUTININ; HEMOZOIN; HEPARAN SULFATE; HYALURONIC ACID; LAURIC ACID; LIPOPOLYSACCHARIDE; MANNAN; MULTIDRUG RESISTANCE PROTEIN 1; OLIGOSACCHARIDE; PATTERN RECOGNITION RECEPTOR; PEPTIDOGLYCAN; PHOSPHOLIPOMANNAN; POLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; ZYMOSAN;

ARTICLE; BACTERIUM; CANDIDA; CLINICAL STUDY; CYTOMEGALOVIRUS; DRUG TARGETING; EXPERIMENTAL MODEL; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; INFLAMMATION; INFLUENZA VIRUS; INNATE IMMUNITY; MEASLES VIRUS; MOLECULAR INTERACTION; MURINE CYTOMEGALOVIRUS; MYCOPLASMA; NONHUMAN; PLASMODIUM; REOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES; SEPSIS; SIGNAL TRANSDUCTION; STREPTOCOCCUS; TOXOPLASMA GONDII; TRYPANOSOMA; UROPATHOGENIC BACTERIA; VESICULAR STOMATITIS VIRUS; WEST NILE FLAVIVIRUS;

EID: 78549289528     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153010791936919     Document Type: Article

References (50)

1. Hoffmann, J.A.; Kafatos, F.C.; Janeway, C.A. and Ezekowitz, R.A. (1999) Phylogenetic perspectives in innate immunity. Science, 284, 1313-1318.
2. Medzhitov, R. (2007) Recognition of microorganisms and activation of the immune response. Nature, 449, 819-826.
3. Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature, 454, 428-435.
4. Mogensen, T.H. (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev., 22, 240-273.
5. Rittirsch, D.; Flierl, M.A. and Ward, P.A. (2008) Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol., 8, 776-787.
6. Mitchell, J.A.; Paul-Clark, M.J.; Clarke, G.W.; McMaster, S.K. and Cartwright, N. (2007) Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol., 193, 323-330.
7. Taguchi, T.; Mitcham, J.L.; Dower, S.K.; Sims, J.E. and Testa, J.R. (1996) Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics, 32, 486-488.
8. Medzhitov, R.; Preston-Hurlburt, P. and Janeway, C.A., Jr. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397.
9. Rock, F.L.; Hardiman, G.; Timans, J.C.; Kastelein, R.A. and Bazan, J.F. (1998) A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA, 95, 588-593.
10. Kumar, H.; Kawai, T. and Akira, S. (2009) Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun., 388, 621- 625.
11. Beutler, B.A. (2009) TLRs and innate immunity. Blood, 113, 1399-1407.
12. [12] Bell, J.K.; Mullen, G.E.; Leifer, C.A.; Mazzoni, A.; Davies, D.R. and Segal, D.M. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol., 24, 528-533.
13. Jin, M.S. and Lee, J.O. (2008) Structures of the toll-like receptor family and its ligand complexes. Immunity, 29, 182-191.
14. Miller, Y.I.; Viriyakosol, S.; Binder, C.J.; Feramisco, J.R.; Kirkland, T.N. and Witztum, J.L. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem., 278, 1561-1568.
15. Slack, J.L.; Schooley, K.; Bonnert, T.P.; Mitcham, J.L.; Qwarnstrom, E.E.; Sims, J.E. and Dower, S.K. (2000) Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J. Biol. Chem., 275, 4670-4678.
16. Lu, Y.C.; Yeh, W.C. and Ohashi, P.S. (2008) LPS/TLR4 signal transduction pathway. Cytokine, 42, 145-151.
17. Wright, S.D.; Ramos, R.A.; Tobias, P.S.; Ulevitch, R.J. and Mathison, J.C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 249, 1431-1433.
18. O'Neill, L.A. and Bowie, A.G. (2007) The family of five: TIRdomain- containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol., 7, 353-364.
19. Jenkins, K.A. and Mansell, A. (2010) TIR-containing adaptors in Toll-like receptor signalling. Cytokine, 49, 237-44.
20. [20] Cook, D.N.; Pisetsky, D.S. and Schwartz, D.A. (2004) Toll-like receptors in the pathogenesis of human disease. Nat. Immunol., 5, 975-979.
21. Christaki, E. and Opal, S.M. (2008) Is the mortality rate for septic shock really decreasing? Curr.Opin. Crit. Care, 14, 580-586.
22. Linde-Zwirble, W.T. and Angus, D.C. (2004) Severe sepsis epidemiology: sampling, selection, and society. Crit. Care, 8, 222-226.
23. Sultzer, B.M. (1968) Genetic control of leucocyte responses to endotoxin. Nature, 219, 1253-1254.
24. Poltorak, A.; He, X.; Smirnova, I.; Liu, M.Y.; Van Huffel, C.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; Freudenberg, M.; Ricciardi-Castagnoli, P.; Layton, B. and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088.
25. Fernandes, C.I.; Llimona, F.; Godoy, L.C.; Negri, E.M.; Pontieri, V.; Moretti, A.I.; Fernandes, T.R.; Soriano, F.G.; Velasco, I.T. and Souza, H.P. (2009) Treatment of hemorrhagic shock with hypertonic saline solution modulates the inflammatory response to live bacteria in lungs. Braz. J. Med. Biol. Res., 42, 892-901.
26. Fan, J.; Kapus, A.; Marsden, P.A.; Li, Y.H.; Oreopoulos, G.; Marshall, J.C.; Frantz, S.; Kelly, R.A.; Medzhitov, R. and Rotstein, O.D. (2002) Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J. Immunol., 168, 5252-5259.
27. Tsujimoto, H.; Ono, S.; Majima, T.; Kawarabayashi, N.; Takayama, E.; Kinoshita, M.; Seki, S.; Hiraide, H.; Moldawer, L.L. and Mochizuki, H. (2005) Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock, 23, 39-44.
28. Williams, D.L.; Ha, T.; Li, C.; Kalbfleisch, J.H.; Schweitzer, J.; Vogt, W. and Browder, I.W. (2003) Modulation of tissue Tolllike receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med., 31, 1808-1818.
29. Andonegui, G.; Bonder, C.S.; Green, F.; Mullaly, S.C.; Zbytnuik, L.; Raharjo, E. and Kubes, P. (2003) Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J. Clin. Invest., 111, 1011-1020.
30. Hoshino, K.; Takeuchi, O.; Kawai, T.; Sanjo, H.; Ogawa, T.; Takeda, Y.; Takeda, K. and Akira, S. (1999) Cutting edge: Tolllike receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol., 162, 3749-3752.
31. Weighardt, H.; Kaiser-Moore, S.; Vabulas, R.M.; Kirschning, C.J.; Wagner, H. and Holzmann, B. (2002) Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J. Immunol., 169, 2823-2827.
32. Takeuchi, O.; Hoshino, K. and Akira, S. (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol., 165, 5392-5396.
33. Medzhitov, R.; Preston-Hurlburt, P.; Kopp, E.; Stadlen, A.; Chen, C.; Ghosh, S. and Janeway, C.A., Jr. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell, 2, 253-258.
34. Kawai, T.; Adachi, O.; Ogawa, T.; Takeda, K. and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity, 11, 115-122.
35. Albiger, B.; Sandgren, A.; Katsuragi, H.; Meyer-Hoffert, U.; Beiter, K.; Wartha, F.; Hornef, M.; Normark, S. and Normark, B.H. (2005) Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol., 7, 1603-1615.
36. Lin, M.T. and Albertson, T.E. (2004) Genomic polymorphisms in sepsis. Crit. Care Med., 32, 569-579.
37. Arbour, N.C.; Lorenz, E.; Schutte, B.C.; Zabner, J.; Kline, J.N.; Jones, M.; Frees, K.; Watt, J.L. and Schwartz, D.A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet., 25, 187-191.
38. Lorenz, E.; Mira, J.P.; Frees, K.L. and Schwartz, D.A. (2002) Relevance of mutations in the TLR4 receptor in patients with gramnegative septic shock. Arch. Intern. Med., 162, 1028-1032.
39. Read, R.C.; Pullin, J.; Gregory, S.; Borrow, R.; Kaczmarski, E.B.; di Giovine, F.S.; Dower, S.K.; Cannings, C. and Wilson, A.G. (2001) A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis., 184, 640-642.
40. Tsujimoto, H.; Ono, S.; Efron, P.A.; Scumpia, P.O.; Moldawer, L.L. and Mochizuki, H. (2008) Role of Toll-like receptors in the development of sepsis. Shock, 29, 315-321.
41. Tsujimoto, H.; Ono, S.; Hiraki, S.; Majima, T.; Kawarabayashi, N.; Sugasawa, H.; Kinoshita, M.; Hiraide, H. and Mochizuki, H. (2004) Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J. Endotoxin Res., 10, 229-237.
42. Armstrong, L.; Medford, A.R.; Hunter, K.J.; Uppington, K.M. and Millar, A.B. (2004) Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol., 136, 312-319.
43. Harter, L.; Mica, L.; Stocker, R.; Trentz, O. and Keel, M. (2004) Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock, 22, 403-409.
44. Martins, P.S.; Brunialti, M.K.; Martos, L.S.; Machado, F.R.; Assuncao, M.S.; Blecher, S. and Salomao, R. (2008) Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit. Care, 12, R25.
45. Wolfs, T.G.; Dunn-Siegrist, I.; van't Veer, C.; Hodin, C.M.; Germeraad, W.T.; van Zoelen, M.A.; van Suylen, R.J.; Peutz- Kootstra, C.J.; Elson, G.; Pugin, J. and Buurman, W.A. (2008) Increased release of sMD-2 during human endotoxemia and sepsis: a role for endothelial cells. Mol. Immunol., 45, 3268-3277.
46. Munoz, C.; Carlet, J.; Fitting, C.; Misset, B.; Bleriot, J.P. and Cavaillon, J.M. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest., 88, 1747-1754.
47. Salomao, R.; Brunialti, M.K.; Kallas, E.G.; Martins, P.S.; Rigato, O. and Freudenberg, M. (2002) Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients. J. Endotoxin Res., 8, 371-379.
48. Brunialti, M.K.; Martins, P.S.; Barbosa de Carvalho, H.; Machado, F.R.; Barbosa, L.M. and Salomao, R. (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock, 25, 351-357.
49. Ogawa, S.; Lozach, J.; Benner, C.; Pascual, G.; Tangirala, R.K.; Westin, S.; Hoffmann, A.; Subramaniam, S.; David, M.; Rosenfeld, M.G. and Glass, C.K. (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell, 122, 707-721.
50. Daynes, R.A.; Jones, D.C. (2002) Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol., 2, 748-759.